OMEROS CORP (OMER)
1 Item 5.02 filing since 2026-10-30 · roles: CEO. Nasdaq. Pharmaceutical Preparations. State: WA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 0 | 2026-10-30 | Compensation only | CEO | subscribers | — | OMEROS CORP (OMER): CEO Gregory A. Demopulos, M.D. compensation terms |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works